Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380910 · ClinicalTrials.gov registry record · NA
An Interprofessional Intervention to Reduce Smoking Rates
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03380910: Completed NA study, sponsored by Virginia Commonwealth University.
NCT03380910 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03380910, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of an experimental process to aid Spanish-speaking patients in quitting smoking with the help of pharmacists and behavioral health psychologist trainees and clinicians.
Primary Outcome
Smoking abstinence will be measured by breath carbon monoxide level
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Pharmacy and Behavioral Health Team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
What the finished NCT03380910 record still lists
NCT03380910 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing is the first listed.
NCT03380910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03380910 about?
NCT03380910 is a clinical study titled "An Interprofessional Intervention to Reduce Smoking Rates". The purpose of this study is to test the effectiveness of an experimental process to aid Spanish-speaking patients in quitting smoking with the help of pharmacists and behavioral health psychologist trainees and clinicians.
What is the current status of trial NCT03380910?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-01-26. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT03380910?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Pharmacy and Behavioral Health Team (BEHAVIORAL).
Who is sponsoring clinical trial NCT03380910?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03380910's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI